BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3856475)

  • 1. Localization of anti-osteogenic sarcoma monoclonal antibody 791T/36 in a primary human osteogenic sarcoma and its subsequent xenograft in immunodeprived mice.
    Pimm MV; Perkins AC; Armitage NC; Baldwin RW
    Cancer Immunol Immunother; 1985; 19(1):18-21. PubMed ID: 3856475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-alpha conjugation to human osteogenic sarcoma monoclonal antibody 791T/36.
    Pelham JM; Gray JD; Flannery GR; Pimm MV; Baldwin RW
    Cancer Immunol Immunother; 1983; 15(3):210-6. PubMed ID: 6577942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibodies for radioimmunodetection of tumours and for targeting.
    Baldwin RW; Embleton MJ; Pimm MV
    Bull Cancer; 1983; 70(2):132-6. PubMed ID: 6575842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor monoclonal antibodies for radioimmunodetection of tumors and drug targeting.
    Baldwin RW; Pimm MV
    Cancer Metastasis Rev; 1983; 2(1):89-106. PubMed ID: 6352009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation between monoclonal antibody-defined antigens on a human osteogenic sarcoma cell line (791T) and tumor-localizing properties of the anti-791T/36 antibody.
    Dawood F; Embleton MJ; Price MR; Pimm MV; Byers VS; Baldwin RW
    Braz J Med Biol Res; 1986; 19(2):257-69. PubMed ID: 3470084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement-dependent cytotoxicity of anti-human osteogenic sarcoma monoclonal antibodies.
    Price MR; Pimm MV; Baldwin RW
    Br J Cancer; 1982 Oct; 46(4):601-10. PubMed ID: 6958308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo radiolocalization of antiosteogenic sarcoma monoclonal antibodies in osteogenic sarcoma xenografts.
    Nakamura T; Sakahara H; Hosoi S; Yamamuro T; Higashi S; Mikawa H; Endo K; Toyama S
    Cancer Res; 1984 May; 44(5):2078-83. PubMed ID: 6585270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo localization of anti-osteogenic sarcoma 791T monoclonal antibody in osteogenic sarcoma xenografts.
    Pimm MV; Embleton MJ; Perkins AC; Price MR; Robins RA; Robinson GR; Baldwin RW
    Int J Cancer; 1982 Jul; 30(1):75-85. PubMed ID: 6956558
    [No Abstract]   [Full Text] [Related]  

  • 9. Localization of an anti-CEA monoclonal antibody in colo-rectal carcinoma xenografts.
    Pimm MV; Armitage NC; Perkins AC; Smith W; Baldwin RW
    Cancer Immunol Immunother; 1985; 19(1):8-17. PubMed ID: 3844977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative evaluation of the localization of a monoclonal antibody (791T/36) in human osteogenic sarcoma xenografts.
    Pimm MV; Baldwin RW
    Eur J Cancer Clin Oncol; 1984 Apr; 20(4):515-24. PubMed ID: 6586422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experience in the preparation and experimental use of immunocytostatics.
    Embleton MJ; Pimm MV; Garnett MC; Rowland GF; Simmonds RG; Baldwin RW
    Behring Inst Mitt; 1984 May; (74):108-12. PubMed ID: 6591915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoscintigraphy of colorectal carcinoma with monoclonal antibody 791T/36.
    Pimm MV; Armitage NC; Perkins AC; Hardcastle JD; Baldwin RW
    Behring Inst Mitt; 1984 May; (74):80-6. PubMed ID: 6591917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective localisation of two radiolabelled anti-sarcoma monoclonal antibodies in human osteosarcoma xenografts.
    Bruland O; Fodstad O; Skretting A; Pihl A
    Br J Cancer; 1987 Jul; 56(1):21-5. PubMed ID: 3476143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigenicity and drug susceptibility of human osteogenic sarcoma cells "escaping" a cytotoxic methotrexate-albumin-monoclonal antibody conjugate.
    Embleton MJ; Garnett MC; Jacobs E; Baldwin RW
    Br J Cancer; 1984 May; 49(5):559-65. PubMed ID: 6586198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumour reactions of monoclonal antibody against a human osteogenic-sarcoma cell line.
    Embleton MJ; Gunn B; Byers VS; Baldwin RW
    Br J Cancer; 1981 May; 43(5):582-7. PubMed ID: 6941806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibody targeting of methotrexate (MTX) against MTX-resistant tumour cell lines.
    Affleck K; Embleton MJ
    Br J Cancer; 1992 Jun; 65(6):838-44. PubMed ID: 1616855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of an anti-human osteogenic sarcoma monoclonal-antibody-defined antigen on mitogen-stimulated peripheral blood mononuclear cells.
    Price MR; Campbell DG; Baldwin RW
    Scand J Immunol; 1983 Nov; 18(5):411-20. PubMed ID: 6359372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies against osteosarcoma and colon cancer.
    Embleton MJ; Brown A; Gunn B; Byers VS; Baldwin RW
    Behring Inst Mitt; 1984 May; (74):35-8. PubMed ID: 6591916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The preparation and characterisation of 111In-labelled 791T/36 monoclonal antibody for tumour immunoscintigraphy.
    Perkins AC; Pimm MV; Birch MK
    Eur J Nucl Med; 1985; 10(7-8):296-301. PubMed ID: 3859410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conjugates of monoclonal antibody 791T/36 with methotrexate in cancer therapy.
    Baldwin RW; Embleton MJ; Garnett MC; Pimm MV
    NCI Monogr; 1987; (3):95-9. PubMed ID: 3469528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.